Hypermarcas (OTCMKTS:HYPMY – Get Free Report) shares saw an uptick in trading volume on Monday . 11,902 shares traded hands during mid-day trading, an increase of 80% from the previous session’s volume of 6,600 shares.The stock last traded at $4.2976 and had previously closed at $4.32.
Hypermarcas Stock Down 2.4%
The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The firm has a 50 day moving average price of $4.54 and a 200-day moving average price of $4.46. The firm has a market cap of $2.73 billion, a price-to-earnings ratio of 18.76 and a beta of 0.72.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share for the quarter. The firm had revenue of $408.83 million during the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Further Reading
- Five stocks we like better than Hypermarcas
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- You Still Think Silver’s a Joke? Watch What Happens Next.
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
